This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
General Electric (GE) Buys Prismatic Sensors, Wins Contracts
by Zacks Equity Research
Healthcare unit of General Electric (GE) acquires the developer of photon counting detectors, Prismatic Sensors, and introduces AI algorithm. GE Power receives two contracts.
Crane (CR) to Benefit From Buyouts and Growth Investments
by Zacks Equity Research
Crane (CR) stands to gain from the exposure in diverse end markets, acquired assets and cost reduction initiatives.
3M's (MMM) October Sales Increase Y/Y in Low-Single Digits
by Zacks Equity Research
3M's (MMM) sales performance in October is driven by gains from acquisitions/divestitures and healthy organic performance. Businesses in geographies flourish well.
5 Reasons Why Danaher (DHR) Stock is Worth Investing in Now
by Zacks Equity Research
Danaher (DHR) to benefit from healthy growth opportunities in Life Sciences and Diagnostics segments, acquired assets and shareholders-friendly policies.
ITT Q3 Earnings and Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
ITT's third-quarter revenues decline 17% year over year on account of lackluster performance across its segments.
Honeywell (HON) Q3 Earnings & Revenues Top Estimates, Down Y/Y
by Zacks Equity Research
Honeywell (HON) third-quarter 2020 revenues decline 14% year over year on account of lackluster performance across most of its segments.
Should Value Investors Buy Crane (CR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3M (MMM) Q3 Earnings Beat Estimates, Fall Y/Y on High Costs
by Zacks Equity Research
3M's (MMM) third-quarter 2020 results reflect gains from higher sales generation as well as adverse impacts of higher costs and expenses, and taxes.
Crane (CR) Q3 Earnings & Revenues Surpass Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) third-quarter 2020 revenues decline 4.9% year over year on lackluster performance across its segments, except Payment & Merchandising Technologies.
Crane (CR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Crane (CR) delivered earnings and revenue surprises of 28.05% and 9.40%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Danaher (DHR) Q3 Earnings Beat, Rise Y/Y on Sales Growth
by Zacks Equity Research
Danaher's (DHR) Q3 results reflect growth in Life Sciences and Diagnostics segments' sales, contribution from Cytiva, and operating margin rise. Core Q4 sales are likely to grow in high-single digits.
Carlisle (CSL) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Carlisle Companies' (CSL) third-quarter 2020 revenues decline 12% year over year on account of lackluster performance across its segments.
Earnings Preview: Crane (CR) Q3 Earnings Expected to Decline
by Zacks Equity Research
Crane (CR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Macquarie (MIC) Displays Bright Prospects, Risks Persist
by Zacks Equity Research
Macquarie (MIC) stands to gain from solid demand for storage of petroleum products, growth projects and shareholder-friendly policies. The coronavirus outbreak-led market downturn remains a concern.
Is Crane (CR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Truth About Market Timing - September 29, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Danaher (DHR) Gains 19% in 3 Months: What's Driving It?
by Zacks Equity Research
Danaher (DHR), with a 19% rise in the past three months, benefits from core sales growth opportunities in Diagnostics and Life Sciences segments, innovation efforts, and shareholder-friendly policies.
The Keys to Successfully Timing the Markets - September 03, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Crane (CR) Up 1.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Crane (CR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Crane (CR) Up 1.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Crane (CR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Crane to Benefit From Acquisitions Amid Pandemic Scares
by Zacks Equity Research
Crane (CR) is likely to benefit from the exposure in diverse end-markets, acquired assets and repositioning initiatives. However, the coronavirus outbreak-led market downturn remains concerning.
Yes, You Can Time the Market. Find out How - August 12, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
3M (MMM) Q2 Earnings Surpass Earnings, Fall Y/Y on Weak Sales
by Zacks Equity Research
3M's (MMM) second-quarter 2020 results reflect the adverse impacts of the coronavirus outbreak, forex woes and inorganic actions, offset by lower taxes, a fall in share count and cost reduction.
Crane (CR) Q2 Earnings and Revenues Beat Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) second-quarter 2020 revenues decline 19.5% year over year on lackluster performance across its segments.
Crane (CR) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Crane (CR) delivered earnings and revenue surprises of 36.17% and 10.79%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?